The sensitivity of cancer cells to HDACis is higher in cells with p53R428W mutations than in cells with a loss of p53 [73], which is consistent with the difference in sensitivity to TSA between Ca9-22 and HSC-2 cells in the present study. Here, TP53 is linked to cancer.